- Home
- HUDI vs GOVX Comparison
HUDI vs GOVX Comparison
Compare HUDI & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- GOVX
- Stock Information
- Founded
- HUDI 2018
- GOVX 2001
- Country
- HUDI China
- GOVX United States
- Employees
- HUDI N/A
- GOVX N/A
- Industry
- HUDI Steel/Iron Ore
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- GOVX Health Care
- Exchange
- HUDI Nasdaq
- GOVX Nasdaq
- Market Cap
- HUDI 18.8M
- GOVX 15.5M
- IPO Year
- HUDI 2021
- GOVX N/A
- Fundamental
- Price
- HUDI $1.34
- GOVX $0.95
- Analyst Decision
- HUDI
- GOVX Strong Buy
- Analyst Count
- HUDI 0
- GOVX 5
- Target Price
- HUDI N/A
- GOVX $12.40
- AVG Volume (30 Days)
- HUDI 14.7K
- GOVX 1.5M
- Earning Date
- HUDI 08-05-2025
- GOVX 08-05-2025
- Dividend Yield
- HUDI N/A
- GOVX N/A
- EPS Growth
- HUDI N/A
- GOVX N/A
- EPS
- HUDI 0.01
- GOVX N/A
- Revenue
- HUDI $74,270,429.00
- GOVX $5,591,576.00
- Revenue This Year
- HUDI N/A
- GOVX N/A
- Revenue Next Year
- HUDI N/A
- GOVX N/A
- P/E Ratio
- HUDI $139.13
- GOVX N/A
- Revenue Growth
- HUDI N/A
- GOVX N/A
- 52 Week Low
- HUDI $1.26
- GOVX $0.73
- 52 Week High
- HUDI $3.45
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- HUDI 41.31
- GOVX 46.22
- Support Level
- HUDI $1.35
- GOVX $0.85
- Resistance Level
- HUDI $1.44
- GOVX $1.39
- Average True Range (ATR)
- HUDI 0.08
- GOVX 0.15
- MACD
- HUDI -0.01
- GOVX -0.02
- Stochastic Oscillator
- HUDI 24.24
- GOVX 18.52
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.